Novogene America Highlights Microbial Sequencing Innovations at ASM Microbe 2025
Los Angeles, CA – June 20–22, 2025 – Novogene America proudly participated in the ASM Microbe 2025 conference, held at the Los Angeles Convention Center. As one of the premier global events for microbiology professionals, ASM Microbe brought together over 15,000 researchers, clinicians, and industry experts to explore the latest advancements in microbial science and technology.
At Booth #2721, Novogene’s team, comprising sales consultants, sequencing scientists, and product managers, engaged with researchers in detailed consultations focused on experimental design, workflow optimization, and data interpretation for microbial sequencing studies. These interactions emphasized Novogene’s expertise in delivering end-to-end, high-throughput sequencing solutions tailored to the complex demands of microbiome and microbial genomics research.
To mark the occasion, Novogene offered an exclusive 15% discount on Microbial Sequencing Projects for ASM Microbe attendees. The company also promoted its Amplicon Metagenomic Sequencing service at special reduced rates, showcasing its capabilities in profiling complex microbial communities with precision and efficiency.
About Novogene
Novogene is a global leader in Next-Generation Sequencing (NGS), Proteomics, and Metabolomics services, empowering researchers and organizations with cutting-edge multi-omics solutions. Since our founding in March 2011, we have remained at the forefront of innovation, delivering world-class services to advance discoveries in life sciences, healthcare, and beyond.
At Novogene, we have built a highly skilled, interdisciplinary team, with the majority holding advanced degrees from top global institutions. Our high-throughput sequencing and high-performance computing platforms are designed to efficiently handle large-scale genomic data, meeting the evolving demands of life sciences and medical research with secure data storage and powerful bioinformatics analysis.
Through extensive collaborations with leading academic institutions, hospitals, pharmaceutical companies, and agricultural enterprises, Novogene continues to shape the future of genomic research and precision medicine. As a trusted genomics partner, we are committed to empowering researchers worldwide with the technology, expertise, and solutions needed to advance genomics and improve life.
